These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17123777)

  • 1. Transcriptional profiling of C2C12 myotubes in response to SHIP2 depletion and insulin stimulation.
    Huard C; Martinez RV; Ross C; Johnson JW; Zhong W; Hill AA; Kim R; Paulsen JE; Shih HH
    Genomics; 2007 Feb; 89(2):270-9. PubMed ID: 17123777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes.
    Suwa A; Kurama T; Yamamoto T; Sawada A; Shimokawa T; Aramori I
    Eur J Pharmacol; 2010 Sep; 642(1-3):177-82. PubMed ID: 20558154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmitate induces SHIP2 expression via the ceramide-mediated activation of NF-κB, and JNK in skeletal muscle cells.
    Gorgani-Firuzjaee S; Ahmadi S; Meshkani R
    Biochem Biophys Res Commun; 2014 Jul; 450(1):494-9. PubMed ID: 24924631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2-containing 5'-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor.
    Prasad NK; Decker SJ
    J Biol Chem; 2005 Apr; 280(13):13129-36. PubMed ID: 15668240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
    Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
    Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
    Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
    J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse.
    Schurmans S; Carrió R; Behrends J; Pouillon V; Merino J; Clément S
    Genomics; 1999 Dec; 62(2):260-71. PubMed ID: 10610720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
    Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
    Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous SHIP2 does not localize in lipid rafts in 3T3-L1 adipocytes.
    Jacobs C; Onnockx S; Vandenbroere I; Pirson I
    FEBS Lett; 2004 May; 565(1-3):70-4. PubMed ID: 15135055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
    Grempler R; Leicht S; Kischel I; Eickelmann P; Redemann N
    FEBS Lett; 2007 Dec; 581(30):5885-90. PubMed ID: 18061583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
    Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
    Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome.
    Buettner R; Ottinger I; Gerhardt-Salbert C; Wrede CE; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1871-8. PubMed ID: 17327370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lipid phosphatase SHIP2 controls insulin sensitivity.
    Clément S; Krause U; Desmedt F; Tanti JF; Behrends J; Pesesse X; Sasaki T; Penninger J; Doherty M; Malaisse W; Dumont JE; Le Marchand-Brustel Y; Erneux C; Hue L; Schurmans S
    Nature; 2001 Jan; 409(6816):92-7. PubMed ID: 11343120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.
    Sleeman MW; Wortley KE; Lai KM; Gowen LC; Kintner J; Kline WO; Garcia K; Stitt TN; Yancopoulos GD; Wiegand SJ; Glass DJ
    Nat Med; 2005 Feb; 11(2):199-205. PubMed ID: 15654325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2-containing inositol 5'-phosphatase 2 selectively impairs hypothalamic insulin signalling and regulation of food intake in mice.
    Ichihara Y; Wada T; Soeda Y; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
    J Neuroendocrinol; 2013 Apr; 25(4):372-82. PubMed ID: 23286299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.